Previous 10 | Next 10 |
SEATTLE, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced that it will release fiscal ...
SEATTLE, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the William Blair Health...
SEATTLE, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the Piper Sandler 32 n...
The following slide deck was published by Accolade, Inc. in conjunction with this event. For further details see: Accolade (ACCD) Presents At Credit Suisse 29th Annual Virtual Healthcare Conference - Slideshow
SEATTLE, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the virtual 29th Annual ...
SEATTLE, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced the closing of its public offerin...
Accolade (ACCD) prices its underwritten public offering of 5M common shares at $38.50 per share.Underwriters have an option to purchase up to 750,000 additional common shares. Closing date is October 26, 2020.Net proceeds will be used for general corporate purposes, including working capital,...
SEATTLE, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (“Accolade”), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced the pricing of its pr...
Accolade (ACCD) commenced an underwritten public offering of 4.50M common stock; expects to grant to the underwriters a 30-day option to purchase an additional 675K of the shares to cover over-allotments.The public offering price has not yet been determined.Net proceeds from the pro...
SEATTLE, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (“Accolade”), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced it has filed a regist...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...